Finasteride: The Generic Form Of Propecia Explained

Finasteride is the generic name of the medication sold under the brand name Propecia. Generic medications contain the same active ingredient at the same dose and strength as their brand name counterparts and must meet the same FDA standards for quality, purity, and bioequivalence. The development and approval of generic drugs play an important role in making effective treatments more accessible and affordable for patients. Allergic conditions affect hundreds of millions of people worldwide and range from mild seasonal symptoms to chronic conditions that persist throughout the year. The immune system's overreaction to harmless environmental substances such as pollen, dust mites, pet dander, and certain foods drives most allergic disease. Histamine, released by immune cells when they detect an allergen, is the primary chemical mediator responsible for the familiar symptoms of sneezing, runny nose, itchy eyes, and skin reactions. The pharmacological action of finasteride is the basis for its use in treating conditions within the category of prostate health. Understanding the mechanism by which the active compound produces its therapeutic effects helps patients appreciate why the medication needs to be taken consistently and at the correct dose to achieve the best results. Switching between brand name and generic versions of a medication is generally considered safe when the products are bioequivalent, but patients should inform their doctor if they notice any differences in effect after a formulary change. Some patients with conditions requiring precise drug levels in the blood may be monitored more closely during transitions. For most patients, however, approved generics provide equivalent therapeutic benefit to the brand name product. The prostate health section on prostate health covers both brand name and generic treatment options, giving patients a complete picture of what is available. Cost, insurance coverage, and pharmacy availability are practical factors to discuss with a pharmacist when filling a prescription for finasteride.

Non-Prescription Strategies That Support Patients Taking Pioglitazone for Diabetes

Patients taking pioglitazone as part of their type 2 diabetes management can benefit from several non-prescription approaches that complement the medication's mechanism and support overall metabolic health. Understanding what is compatible with thiazolidinedione therapy helps patients make informed lifestyle and supplement decisions. Physical activity is the most well-validated non-pharmacological complement to pioglitazone. Both the medication and exercise improve insulin sensitivity, and their effects are additive. Regular aerobic and resistance exercise improves glucose uptake by muscle cells independently of insulin, supports weight management to offset the modest weight gain associated with pioglitazone, and provides cardiovascular benefit. Patients who achieve consistent physical activity as part of their routine may require lower pioglitazone doses to maintain glucose targets. Dietary fiber intake from food sources or soluble fiber supplements such as psyllium husk reduces post-meal glucose spikes by slowing carbohydrate absorption. Psyllium-containing products available without a prescription are well tolerated and do not interact adversely with pioglitazone. Consistent fiber intake over time is associated with improvements in HbA1c in observational diabetes studies. Berberine is a plant-derived compound available as an OTC supplement that has demonstrated modest glucose-lowering effects in small clinical studies. Patients who take berberine alongside pioglitazone should inform their provider, as the additive glucose effects could theoretically increase hypoglycemia risk, particularly if insulin or a sulfonylurea is also part of the regimen. Alpha-lipoic acid supplements are used by some patients with diabetes for metabolic support and to address peripheral neuropathy symptoms. No significant pharmacokinetic interaction with pioglitazone has been identified, and the supplement is generally considered to have a tolerable safety profile at standard supplemental doses. Patients on pioglitazone should monitor their body weight regularly because weight gain from fluid retention and adipose redistribution is a recognized effect. Home scale monitoring allows patients to identify unexplained rapid weight gain that could indicate fluid retention rather than gradual metabolic weight gain. This distinction matters for clinical follow-up and should prompt contact with the provider if more than a few pounds accumulate over a short period. Bone health support is particularly relevant for women taking pioglitazone long-term given the association with increased fracture risk. Adequate calcium intake from dietary sources and vitamin D supplementation support bone mineral density maintenance. Patients should discuss bone health monitoring with their provider as part of long-term pioglitazone care. Patients using pioglitazone for glucose management who want to understand complementary lifestyle and supplement strategies can find relevant information about over the counter options combined with pioglitazone therapy for a comprehensive view of self-care support. For patients seeking context on how pioglitazone fits into the broader diabetes treatment landscape alongside other agents, diabetes medication guides and patient resources offers useful comparative information.

Triamterene for Fluid Balance: How This Potassium-Sparing Diuretic Works and When It Is Used

Triamterene is a potassium-sparing diuretic that acts in the collecting duct of the kidney to block sodium channels, reducing sodium reabsorption and promoting its excretion in urine. Unlike thiazide and loop diuretics that cause potassium loss, triamterene conserves potassium by preventing the exchange mechanism that ordinarily loses potassium while reabsorbing sodium. This property makes it particularly useful when diuresis is needed without the electrolyte trade-off of potassium depletion. Triamterene is most commonly used in combination with hydrochlorothiazide rather than as a standalone diuretic. The combination is available as a fixed-dose product and addresses the potassium-wasting effect of thiazide diuretics by pairing them with a potassium-retaining agent. Patients who develop hypokalemia on HCTZ alone are frequently switched to a combined product containing triamterene. The combination is prescribed for hypertension and for edema in patients where maintaining potassium balance is a clinical priority. As sole therapy, triamterene is a relatively weak diuretic. Its primary value lies in its potassium-sparing effect rather than a strong increase in urine volume. Prescribers who choose it as standalone therapy are typically targeting potassium preservation rather than aggressive fluid removal. Triamterene is categorized differently from spironolactone and eplerenone, which are also potassium-sparing agents. While spironolactone and eplerenone work by blocking aldosterone receptors, triamterene works directly on the sodium channel in the collecting duct regardless of aldosterone levels. This mechanistic difference matters for patient populations where aldosterone status is relevant, such as primary aldosteronism. Hyperkalemia is the main electrolyte concern with triamterene use. Elevated potassium levels can occur, especially when triamterene is combined with ACE inhibitors, angiotensin receptor blockers, potassium supplements, or in patients with reduced kidney function. Monitoring of serum potassium and kidney function is standard practice when triamterene is part of the regimen. Triamterene has a less favorable profile with respect to kidney stone formation compared to other diuretics. It can precipitate in the renal tubules and form triamterene kidney stones, which is an uncommon but recognized adverse effect. Patients with a history of nephrolithiasis should have this consideration discussed before therapy is initiated. Prescribers evaluate the complete clinical picture including kidney function, concurrent medications, and electrolyte baseline before selecting triamterene or a triamterene-containing combination product. For patients seeking to understand how this potassium-sparing diuretic is used in clinical settings, exploring information about triamterene for fluid balance management provides a useful clinical overview. For comparison with the broader diuretic class and how agents are matched to specific patient needs, diuretic medication category patient guides offers helpful context.

Topamax: Brand Name Medication Guide For Seizure And Epilepsy Treatment

Topamax is the brand name for topiramate, a medication used in the management of conditions associated with seizure and epilepsy treatment. Brand name medications are pharmaceutical products marketed under a proprietary name by the company that originally developed them. Understanding the relationship between brand name and generic formulations, as well as the conditions for which the medication is approved, helps patients make informed choices about their treatment. Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures caused by sudden, abnormal electrical activity in the brain. Seizures vary widely in their manifestation, from brief lapses in consciousness lasting only seconds to full convulsive episodes involving the entire body. The specific seizure type, the region of the brain involved, and the underlying cause of the epilepsy are all important factors in determining the most appropriate treatment approach. The brand name Topamax has built a clinical track record through use in a wide range of patients and healthcare settings. Brand versions and their generic equivalents contain the same active ingredient at the same strength, but may differ in inactive ingredients such as fillers, binders, and coatings. In most cases, generic formulations are therapeutically equivalent and offer cost savings, though some patients prefer to stay on a specific formulation for consistency. When prescribed Topamax, patients should follow the guidance of their prescribing physician regarding dose, frequency, and duration of therapy. The medication should be stored as directed on the label, typically at room temperature away from heat and moisture. Any unused medication should not be disposed of by flushing down the drain unless the label specifically says to do so, as this can harm the environment. Comprehensive details on Topamax and other medications used for seizure and epilepsy treatment are available through seizure and epilepsy treatment. This resource provides evidence-based summaries to help patients and healthcare providers stay informed about treatment options in this therapeutic area.

Skin Conditions and Acne

By http://www.webmd.com/skin-problems-and-treatments/acne/acne

Most people develop acne - the most common skin condition - to some degree, but it primarily affects teenagers undergoing hormonal changes.

Acne may be mild (few, occasional pimples), moderate (inflammatory papules), or severe (nodules and cysts). Treatment depends on the severity of the condition.

Adult Skin Problems: See Pictures of Blackheads and Whiteheads

What Causes Acne?

Acne is primarily a hormonal condition driven by male or ‘androgenic’ hormones, which typically become active during the teenage years. Sensitivity to such hormones, combined with bacteria on the skin, and fatty acids within oil glands, cause acne. Common sites for acne are the face, chest, shoulders, and back - the sites of oil glands.

Acne lesions include whiteheads, blackheads, small bumps, and nodules and cysts.

Though acne is essentially a normal physiologic occurrence, certain conditions may aggravate the condition, including:

Fluctuating hormone levels around the time of menses (women)
Manipulating (picking/prodding) acne lesions
Clothing (for example, hats and sports helmets) and headgear

How Is Acne Treated?

Only three types of drugs have proven to be effective for the treatment of acne - antibiotics, benzoyl peroxide, and retinoids. Most people require at least one or two agents, depending on the severity of their acne.

Benzoyl peroxide, available as an over-the-counter product (for example, Clearasil, Stridex) and by prescription (for example, Benoxyl, PanOxyl, Persagel), targets surface bacteria, which often aggravate acne. Irritation (dryness) is a common side effect.
Retinoids (vitamin A derivatives), for example, Differin, Retin-A, Tazorac, treat blackheads and whiteheads, the first lesions of acne. The most common side effect is irritation. While most are prescription only, there is an over-the-counter version of Differin now available.
Antibiotics , either topically applied to the skin (clindamycin, erythromycin), or taken orally (tetracycline and its derivatives, ethoprim-sulfamethoxazole) control surface bacteria and reduce inflammation in the skin. Antibiotics are more effective when combined with benzoyl peroxide or retinoids. The oral retinoid isotretinoin (Absorica, Amnesteem, Claravis, Myorisan and Zenatane) is reserved for people with severe (nodular or cystic) disease. Isotretinoin shrinks the size of oil glands, the anatomic origin of acne. Without active, plump oil glands, acne actively diminishes. Side effects can include dry skin, elevated cholesterol and triglycerides, and birth defects. Women of childbearing age must practice birth control before, during, and after treatment (often a year) with isotretinoin. The use of isotretinoin requires rigorous testing (cholesterol, pregnancy) and follow-up for the prescribed period (5 or more months). It is reserved for the most severe types of acne that do not respond to other treatments.
Hormone therapy may be helpful for some women with acne, especially for those with signs and symptoms (irregular periods, thinning hair) of androgen (male hormone) excess. The hormone therapy consists of low-dose estrogen and progesterone (birth control pills) or anti-androgen medications (spironolactone).

How Can Acne Be Prevented?

To prevent acne and reduce its damage to your skin, follow these tips.

Choose a cleanser specially formulated for acne. These products often contain salicylic acid or benzoyl peroxide, which help to clear acne sores.
Clean your face gently, as trauma to the acne breakouts may worsen the acne or cause scarring. When washing your face, use your hands or cotton pads, as any terrycloth or other scrubbing material may cause acne sores to rupture.
If you need to use a moisturizer, use only light, noncomedogenic moisturizers, which do not aggravate acne.
If you are a woman, use an oil-free foundation. Heavy makeup or other cosmetic products that block pores may cause a flare-up of acne.

Source: http://www.webmd.com/skin-problems-and-treatments/acne/acne

Buy Accutane (Isotretinoin) online, Accutane no prescription by doctor7online.com, nothing worked as Accutane for acne, licensed pharmacy where you can order cheap Accutane. Accutane (isotretinoin) must not be used by female patients who are or may become pregnant. Brand and generic Accutane for sale. No RX Needed! Official Online Pharmacy. Big Discounts! Accutane online for sale.

A Pinworm Medication Is Being Tested As A Potential Anti-Cancer Drug

By www.npr.org

Cancer researchers are testing whether a generic drug that has been used for more than 40 years to treat parasitic infections may also help fight cancer.

The tests of mebendazole are part of a growing effort to take a fresh look at old medicines to see if they can be repurposed for new uses.

I first learned about mebendazole several years back when my son came home from camp with a gross but common infection: pinworms.

My pediatrician prescribed two doses of mebendazole, and two weeks later the infection was gone.

Flash-forward a couple of years, and I was surprised to find on clinicaltrials.gov, the federal database of medical trials, that mebendazole was being investigated as a potential cancer drug.

Curious, I contacted Gregory Riggins, a cancer researcher at Johns Hopkins University who is testing the safety of mebendazole as a potential cancer treatment. He invited me to his lab in Baltimore.

Riggins took me inside and showed me cages of cancer research mice. A few years back, he said, his idea to test mebendazole started here.

Some of the lab animals got infected with pinworms, the same parasite my son had. The veterinarian at Johns Hopkins treated the whole colony of mice with an animal version of mebendazole.

The drug staved off the parasite, but it also did something surprising. Before the mice were treated for pinworms, Riggins and his team had implanted cancer cells into the animals' brains.

But after the mice got the pinworm drug, the cancers never developed. "Our medulloblastoma stopped growing," Riggins says. He found out that other researchers were conducting animal studies to see if the drug had effects on lung cancer and melanoma.

So he got funding to do two Phase 1 studies to test whether mebendazole is safe to use in brain cancer patients, one in children and another in adults. So far the drug appears to be safe and well tolerated by patients, Riggins says. That would be expected, given that it has been used for decades around the world to treat pinworms.

"Based on the preclinical studies it looks like it has promise," says Tracy Batchelor, director of the division of neuro-oncology at Massachusetts General Hospital, who is not involved in the research. "The next step is to look for a benefit in a Phase 2 trial." That would test whether mebendazole has any effect on cancer in people. Riggins hopes to conduct that sort of trial in adult brain cancer patients.

At a time when it can cost a billion dollars to develop a new drug, the idea of repurposing existing drugs is appealing, according to Bruce Bloom. He's the president and chief science officer of Cures Within Reach, which has helped to fund Riggins' research.

Bloom points to research on metformin, a diabetes drug that's being looked at as a potential treatment for a dozen different kinds of cancer and also tuberculosis. A common blood pressure drug, propranolol, is also being studied.

"It's not likely that mebendazole or any other single repurposed drug is ever going to cure cancer," Bloom says. But he envisions the possibility that combinations of repurposed drugs might help the body to manage cancer.

Any use of mebendazole as a cancer drug would be years away, if it proves to work at all. Most drugs that emerge from Phase 1 trials never deliver the hoped-for benefits.

And in an odd twist to a complicated story, the cost of mebendazole in the U.S. has skyrocketed in recent years. Though it remains very affordable in most countries, the wholesale cost of a 100 mg tablet in the U.S. has risen from $4.50 in 2011 to $369 in 2016, according to Truven Health Analytics.

The dynamics that led to the price hike were in play before interest rose in the drug as a potential cancer treatment, analysts say. In 2013, Amedra Pharmaceuticals bought marketing rights to mebendazole from Teva Pharmaceuticals. It already owned rights to another key generic antiparasitic drug, albendazole.

"At that point, anyone who has had a high school or undergraduate economics course would be able to explain the price hike," says Joey Mattingly, an assistant professor in the department of pharmacy practice and science at the University of Maryland School of Pharmacy who studies generic drug pricing.

That leaves people with pinworm infections with the choice of two expensive prescription medications or cheaper over-the-counter options.

"Pinworms are exceedingly common," says Rachel Orscheln, an assistant professor of pediatric infectious diseases at Washington University and St. Louis Children's Hospital. The CDC estimates 40 million people are infected in the U.S. annually. Orscheln says the people most likely to be infected are children and people who are living in group settings such as nursing homes.

"There are certain cases where we do need to prescribe this medication," says Orscheln. But at the higher price, she says, "I'm very disinclined to prescribe [it]." She says over-the-counter drugs such as Pin-X or pyrantel, can work just as well in children, so "I'm very likely to steer people in that direction."

Source: http://www.npr.org/sections/health-shots/2017/01/30/512400204/a-pinworm-medication-is-being-tested-as-a-potential-anti-cancer-drug